30 C
Vientiane
Sunday, May 25, 2025
spot_img
Home Blog Page 105

Jetcraft builds on US momentum with senior sales appointment

LONDON, May 7, 2025 /PRNewswire/ — Jetcraft, the global leader in business aircraft sales, acquisitions, and trades, is today announcing the appointment of Philip Baer as a Sales Director in the United States.

 

Philip Baer, Sales Director, Jetcraft
Philip Baer, Sales Director, Jetcraft

 

Based in Dallas, Baer will lead sales across the South Central territory, including Arkansas, Arizona, Louisiana, New Mexico, Oklahoma, and Texas. His appointment further boosts Jetcraft’s US market presence, bringing extensive local expertise to Jetcraft’s expanded Americas sales team.

Prior to joining Jetcraft, Baer spent two decades with NetJets and NetJets Europe, leading a team responsible for half the company’s billion-dollar revenue.

Chris Hollingsworth, RVP Sales, Americas, says: “North America is at the forefront of pre-owned aircraft transactions, and we remain committed to expanding our thriving team to continue to meet the needs of this dynamic region, ensuring our customers have access to the best advice and aircraft for their missions.

“Philip’s proven leadership, sharp commercial instinct and commitment to the very best in market intelligence make him an exceptional addition to Jetcraft.”

Baer is multilingual and holds an Executive MBA from SMU Cox School of Business, an MSc from the University of Oxford and an FAA Private Pilot License. His appointment follows the promotions of Chris Hollingsworth and Sean O’Leary to Regional Vice Presidents (RVPs) – moves that further cement Jetcraft’s strength and agility across North America.

For more information, please contact 8020 Communications.
Email: jetcraft@8020comms.com
Telephone: +44 (0)1483 447380

About Jetcraft    

More than brokers, Jetcraft® is a network of global aircraft advisors, offering unmatched international reach and unrivalled local knowledge. The company’s market leading intelligence, strategic financing solutions and extensive inventory support even the most intricate of transactions. For over 60 years Jetcraft has led the way, setting standards that continue to shape the industry. Today, a team of 100+ dedicated aviation specialists across 30+ offices deliver worldwide aircraft sales, acquisitions and trading at the speed of life.   

www.jetcraft.com

 

 

GRVT Launches Biggest Ever Trading Competition for Retail Traders, Offering Up to 175,000 USDT in Prizes

SINGAPORE, May 7, 2025 /PRNewswire/ — GRVT (pronounced “gravity”), the world’s first licensed onchain exchange – is excited to announce its largest trading competition to date, running from May 7 to June 5, 2025. The competition offers retail traders the chance to win a share of up to 175,000 USDT and 85 million Trader Points.

GRVT Trading Competition
GRVT Trading Competition

The event is open to all KYC-verified GRVT users and features a volume-based rewards system with nine reward bands and 15 prize levels. Participants will be rewarded based on their total trading volume during the competition period. The total reward pool will expand as the overall trading volume increases.

Early participants can also take advantage of special bonus rewards, and lucky traders will receive exclusive GRVT-branded merchandise.

Hong Yea, co-founder and CEO of GRVT, commented, “This trading competition marks the biggest event for our retail traders since our Mainnet launch at the end of last year. I am incredibly proud of what the team has delivered since Mainnet, and I’m grateful for the enthusiasm and support from our global community. We are committed to continuous improvement and look forward to bringing even more exciting opportunities to our users.”

For full details about the GRVT Trading Competition, including the complete rules and reward structure, please visit: https://help.grvt.io/en/articles/11168184-grvt-trading-rush

Disclaimer: Perpetuals trading of cryptocurrencies is subject to high market risk and price volatility and you may be called upon at short notice to commit further margin deposits or risk being liquidated. This content is not a distribution of, or an offer or solicitation to provide, financial services or products, nor a representation as to their suitability or legality for you. GRVT is not a regulated entity and your funds are not subject to regulatory protection. Before making any decision based on this content, please seek financial and legal advice, and carefully review our Risk Disclosure and Disclaimer in full.

Singapore users: GRVT is not licensed, approved, authorised, designated, recognised, registered or otherwise regulated under any legislation administered by the Monetary Authority of Singapore (“MAS”). As such, users will not have the benefit of any regulatory safeguards imposed by the MAS.

About GRVT

GRVT (pronounced “gravity”) is a blockchain-based platform that is democratizing how wealth is created and shared. It allows everyday people to trade, invest, and grow their wealth by providing direct access to top industry traders and investors. As the world’s first licensed onchaindecentralized exchange, GRVT is where traditional banking meets decentralized innovation on one regulated, compliant, trustless financial market place.

GRVT official website: https://grvt.io/

For media inquiries, contact: press@grvt.io

Social and Community: X | LinkedIn | Telegram | Discord

 

Bosowa Energy Group and BK LNG Solution Forge Strategic Partnership to Accelerate Indonesia’s Energy Transition

JAKARTA, Indonesia, May 7, 2025 /PRNewswire/ — Bosowa Energy Group has announced a strategic partnership with BK LNG Solution (BKLS), marking a significant milestone in its long-term vision to modernize Indonesia’s energy infrastructure and accelerate the shift toward cleaner energy alternatives.

The partnership was formalized through the signing of a Memorandum of Understanding (MOU) in Jakarta, launching a comprehensive collaboration across the liquefied natural gas (LNG) and broader energy infrastructure sectors.

Indonesia’s Bosowa Energy Group and BK LNG Solution officially signed a strategic cooperation MOU in Jakarta
Indonesia’s Bosowa Energy Group and BK LNG Solution officially signed a strategic cooperation MOU in Jakarta

Under the MOU, the two parties will cooperate closely in multiple areas, including LNG supply chain integration, development of floating storage units (FSUs), natural gas power generation, downstream energy applications, and small-scale LNG distribution via ISO tank containers.

During the signing ceremony, representatives from both sides engaged in in-depth discussions on the strategic roadmap and future direction of cooperation.

Indonesia’s Bosowa Energy Group and BK LNG Solution officially signed a strategic cooperation MOU in Jakarta
Indonesia’s Bosowa Energy Group and BK LNG Solution officially signed a strategic cooperation MOU in Jakarta

Muhammad Akram, Chief Operating Officer of Bosowa Energy Group, described the partnership as a transformative step in advancing the nation’s energy transition agenda:
“This collaboration not only enables us to diversify our energy portfolio with scalable LNG solutions, but also directly supports our mission to reduce emissions, enhance energy reliability in underserved regions, and contribute meaningfully to Indonesia’s broader decarbonization goals.”

Junizwan, CEO of Bosowa Energasindo, emphasized the strategic value of the collaboration:
“This collaboration with BK LNG Solution represents a key milestone for Bosowa Energasindo as we strengthen our commitment to Indonesia’s energy transformation. By combining our domestic operational capabilities with BKLS’s international LNG expertise, we are building a foundation for a more agile, efficient, and sustainable energy future.”

Henry Kim, President of BKLS, highlighted the company’s commitment to supporting Indonesia’s clean energy transition:
“As a specialist in flexible LNG solutions with extensive experience across the region, we are confident in our ability to deliver reliable and efficient natural gas solutions tailored to Indonesia’s unique needs, which we believe are essential for a resilient energy transition. This partnership not only initiates resource synergy but also demonstrates our shared commitment to Indonesia’s clean energy goals.”

A key component of the partnership involves converting existing diesel-fired power plants (PLTD) on remote islands into cleaner, gas-fired power plants (PLTG) using LNG. This initiative is expected to significantly reduce greenhouse gas emissions while improving energy stability in underserved regions.

The partnership will also focus on the deployment of modular LNG regasification units and the development of localized micro-grid systems. These technologies are expected to play a critical role in enabling isolated areas across Indonesia to transition from diesel to natural gas—aligning with the nation’s vision for equitable and sustainable energy access.

Initial pilot projects are scheduled to launch in Eastern Indonesia later this year, with plans to expand operations nationwide in the coming years.

This partnership not only aligns with Indonesia’s national energy transition roadmap but also establishes a solid foundation for BKLS to deepen its regional presence and expand its global footprint. By joining forces, Bosowa and BKLS aim to accelerate project execution and contribute to sustainable energy development across Indonesia and the wider Southeast Asian region.

Aeson Power Showcases Innovative Sodium Battery Technology at EES Europe 2025

MUNICH, May 7, 2025 /PRNewswire/ — At EES Europe 2025, one of the leading events for the energy storage industry, Aeson Power debuted its sodium products including the SIBPOM-4850 for telecommunications, the SIBPOM-12100 for UPS, the SIBPOM-125kWh energy storage cabinet for C&I-scale, and the NaForce and NaPulse for passenger cars.

Aeson Power & The Smarter E Europe
Aeson Power & The Smarter E Europe

Aeson Power’s sodium products utilize NFPP polyanionic technology battery cells. The products feature intrinsic safety (capacity can be fully restored after discharging to zero volts), excellent high-temperature resistance (cells operate normally at 60 C), superior rate performance, high charge-discharge efficiency (RTE easily exceeds 95%), and long life (over 15,000 cycles).

For the C&I energy storage, Aeson Power launched sodium product SIBPOM-125kWh energy storage cabinet with safety, intelligence, wide temperature range, and high energy density, and has passed strict third-party tests based on lithium battery standards such as IEC 62619 and IEC 62933.

For the vehicle, Aeson Power introduced two series of sodium-ion batteries ─ the NaForce following European standards (EU) and NaPulse following Japanese standards (JIS) ─ each of which includes both a start-stop option and a starting option and provides instant starting at extreme temperatures, fast charging, light weight design and long service life, especially the start-stop batteries, which have a deep cycle capacity of 180,000. They are suitable for passenger cars and the best alternative to AGM and MF batteries.

Along with the sodium product, Aeson Power also displayed the lithium battery energy storage products – a 261kWh C&I energy storage cabinet and a 5MWh containerized energy storage system – certified to IEC standards by TÜV SÜD and French BV and the bipolar lead-acid battery – TRE, TUS, TSS, THS series – with excellent PSoC cycling, better cranking performance, and high power output.

Aeson Power’s general manager Shirley Zhang stated, “Our bipolar lead-acid batteries are globally unique in low temperature of -40C performance, with wide market adoption. Now, our sodium-ion batteries will also achieve breakthroughs. The safety of sodium battery technology is a critical foundation for future applications. Aeson Power will keep focusing R&D resources on sodium technology.”

About Aeson Power

Aeson Power is a trusted Australian provider of reliable energy solutions, including industry-proven batteries and cutting-edge energy storage solutions. Aeson Power has built an innovation ecosystem, spanning material selection, cell design, and system integration and become a pioneer in next-generation energy storage solutions. Visit www.aesonpower.com for more information.

Media Contact

Ivans Xu
ivansxu@aesonpower.com

Plusgrade and Atlantis Dubai Partner to Enhance Guest Experiences with Seamless Upgrade Solutions

  • Tailored luxury: Guests at Atlantis Dubai’s two resorts – Atlantis, The Palm and Atlantis The Royal – can now access premium room upgrades, stay extensions, and experiences with ease.
  • Seamless integration: Plusgrade’s enterprise upselling platform integrates with Atlantis Dubai’s systems to automate and personalize upsell offers.
  • Proven success: Building on a successful pilot, this partnership sets a new standard for upsell in ultra-luxury hospitality.

MONTREAL, May 7, 2025 /PRNewswire/ — Plusgrade, a global leader in ancillary revenue solutions for the travel industry, is thrilled to announce its partnership with Atlantis Dubai’s two premier luxury resorts: Atlantis, The Palm and Atlantis The Royal. This collaboration introduces an innovative solution that enhances the guest experience by offering seamless access to premium room upgrades, stay extensions, and exclusive experiences, unlocking new revenue opportunities through an intelligent, fully automated, and white-labeled platform.

A Smarter Approach to Personalized Luxury

With this seamless integration, Atlantis Dubai replaces a legacy system with an intuitive, fully automated platform. Now, guests can bid on or purchase upgrades in a way that is effortless, highly personalized, and aligned with the resort’s commitment to world-class hospitality. Beyond premium room upgrades, the platform provides guests with even more opportunities to enhance their stay, offering greater flexibility and choice throughout their journey.

The initiative follows a successful pilot at Atlantis, The Palm, where Plusgrade’s solution increased both guest satisfaction and incremental revenue, reinforcing its value as a strategic hospitality technology partner.

Elevating Every Guest Stay

“The power of bidding technology transforms the way travelers interact with their journey,” said Daniele Carrai, Vice President, Revenue Management, Atlantis Dubai. “Having seen the value of Plusgrade’s solutions during my time in the cruise industry, I am thrilled to bring this level of innovation to Atlantis Dubai. Our ‘innovation partnership’ with Plusgrade allows us to push boundaries and continuously evolve our guest offerings. Their commitment to delivering against our unique needs has made them an invaluable partner as we work together to redefine luxury travel.”

“At Atlantis, our guests expect a level of luxury and personalization that sets new benchmarks in the ultra-luxury market,” said Michael Chatzidakis, Director, Revenue Management, Atlantis Dubai. “The ease of using Plusgrade’s intelligent platform allows us to elevate every aspect of the guest journey, offering tailored services and experiences that make each stay unforgettable.”

Powering the Future of Guest Engagement

“Our partnership with Atlantis Dubai is a perfect example of how technology can enhance the guest experience while driving significant ancillary revenue,” said Ken Harris, Founder and CEO of Plusgrade. “By integrating our intelligent upgrade solution, along with other personalized upsell opportunities, we are giving guests greater choice and flexibility while helping Atlantis Dubai unlock new revenue streams. We are proud to work with these iconic resorts to set a new benchmark for luxury hospitality.”

Key Benefits of the Program

  1. Exclusive Upgrades: Guests can bid on or purchase room upgrades, ensuring a tailored and elevated stay.
  2. Seamless Experience: Fully integrated with Atlantis Dubai’s brand and booking systems for effortless personalization.
  3. Maximized Guest Engagement: A range of upsell opportunities ensures every guest can enhance their stay in a way that suits their needs.

This partnership marks a major step in Atlantis Dubai’s commitment to innovation in hospitality, delivering a more personalized and seamless guest experience. With bidding capabilities now live, guests at Atlantis, The Palm and Atlantis The Royal can instantly access exclusive upgrades and experiences.

About Plusgrade

Plusgrade powers the global travel industry with its portfolio of leading ancillary revenue solutions. Over 250 airline, hospitality, cruise, passenger rail, and financial services companies trust Plusgrade to create new, meaningful revenue streams through incredible customer experiences. As the ancillary revenue powerhouse, Plusgrade has generated billions of dollars in new revenue opportunities across its platform for its partners, while creating enhanced travel experiences for millions of their passengers and guests. Plusgrade was founded in 2009 with headquarters in Montreal and has offices around the world. For more information, visit plusgrade.com.

About Atlantis Dubai

Atlantis Dubai is a world-renowned luxury destination comprised of two iconic resorts, Atlantis, The Palm and Atlantis The Royal, offering unparalleled opulence, adventure, and hospitality. Atlantis, The Palm is the region’s first entertainment resort, home to the world-famous Aquaventure World Waterpark with record-breaking slides, The Lost Chambers Aquarium with over 65,000 marine animals, and a vibrant culinary scene featuring Michelin-starred and celebrity chef restaurants. Atlantis The Royal redefines ultra-luxury with cutting-edge design, offering experiences like sky-high pools, fire-breathing fountains, and the world’s largest collection of celebrity chef restaurants. Recognized as the 9th best resort in the world by The World’s 50 Best Resorts 2024, Atlantis The Royal sets a new benchmark for luxury. From award-winning dining and world-class entertainment to awe-inspiring architecture, Atlantis Dubai is where extraordinary moments come to life.
https://www.atlantis.com/

Media Contact: Carrie Moench, Director, Brand & Communications, Plusgrade, pr@plusgrade.com

Pharos Network Unveils High-Performance Layer 1 Testnet to Unlock RWA Adoption

HONG KONG, May 7, 2025 /PRNewswire/ — Pharos Network, a high-performance blockchain built for real-world assets (RWAs), announced the launch of its Testnet today. Designed for institutional-grade RWAs and enterprise-scale DeFi, Pharos offers a next-generation, modular infrastructure that addresses the key bottlenecks preventing institutions from entering Web3. The platform powers scalable deployment of decentralized applications, enables efficient payment solutions, and unlocks new use cases for tokenized assets.

The Pharos Testnet achieves up to 30,000 transactions per second with one-second finality, setting a new benchmark for Layer 1 blockchain performance. Its GPU-like architecture could support billions of users and reduce storage usage by 80%. The network also features built-in support for decentralized AI and privacy preserving SPN. With ZK-based KYC/AML capabilities, Pharos ensures enterprise-ready security and compliance. It remains fully EVM-compatible, offering faster and cheaper transactions, while enabling flexible, on-chain innovation.

Pharos’s product stack directly addresses the core bottlenecks in RWA adoption—scalability, compliance, and flexibility—unlocking new use cases across sectors such as renewable energy industry finance, payment, supply chain finance, and tokenized real estate. Its modular, high-throughput infrastructure enables secure deployment of RWA at scale, while meeting the regulatory and performance demands of the financial industry.

A growing ecosystem is already emerging on the Pharos Testnet, enabling innovative Defi use cases for RWAs. As an early collaborator of Pharos, OKX Wallet will support Pharos Testnet natively at launch. Early Pharos ecosystem projects include Zenith Swap, ELFi, Buzzing Club, Nextmate.AI, Faroswap, R2, OpenFi, Hemera, Blocksense, Supra, and more.

Founded by former AntChain and Alibaba blockchain leaders, the Pharos team brings deep enterprise experience, uniquely positioning it to deliver enterprise-grade solutions for institutions exploring green finance, payments, and new forms of programmable ownership and asset tokenization.

“The Pharos Testnet represents a significant milestone in our mission to unlock the true potential of RWAs. By providing a high-performance, scalable, and adaptable platform, Pharos meet the needs of bringing real world assets on a chain and bringing utilities to these assets.” said Alex Zhang, CEO of Pharos Network. “We’re excited to watch innovation flourish on Pharos and accelerate the convergence of traditional finance and decentralized technology.

Developers and users can access and experience the Testnet by visiting testnet.pharosnetwork.xyz.

About Pharos

Pharos Network is a revolutionary Layer 1 blockchain platform that sets new benchmarks in decentralized technology with its extreme performance and scalability. Founded by ex-blockchain leaders from Ant Financial and Alibaba, Pharos aims to build the best chain for RWAs and enterprise-grade DeFi, achieving the highest EVM Layer-1 performance with 50K TPS and being the first to reach 2 gigagas/sec. In addition, Pharos is a co-developer of SmartCogent, an AI toolkit for large language models (LLMs), and the core development team of DTVM technology. For more information, please visit https://pharosnetwork.xyz.

TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of ‘Merigolix (TU2670/DW4902)’ for Uterine Fibroids

  • Primary Endpoint Met: Statistically significant reduction in heavy menstrual bleeding achieved in all dosage of Merigolix groups compared to placebo
  • Broader Therapeutic Potential: Positive Phase 2 results in both uterine fibroids and endometriosis could place Merigolix as a strong best-in-class candidate for novel drug approval and global licensing opportunities
  • Multi-Indication Development: Clinical trials are underway for three indications enhancing the asset value-uterine fibroids, endometriosis, and assisted reproductive technology (ART), the latter in collaboration with Hansoh Pharma in China

SEONGNAM, South Korea, May 7, 2025 /PRNewswire/ — TiumBio (KRX: 321550.KQ), a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics for patients with rare and incurable disease, today announced that Merigolix (code name: TU2670, Daewon’s code name: DW4902) has successfully met the primary endpoint of reducing heavy menstrual bleeding in a Phase 2 clinical trial for uterine fibroids. In this trial, Merigolix demonstrated statistically significant improvements across all dosage groups compared to placebo in patients with uterine fibroids.

Merigolix is an investigational, once-daily, oral gonadotropin-releasing hormone (GnRH) receptor antagonist. Unlike traditional GnRH agonists, which require injection and often lead to an initial hormone surge, Merigolix offers a more patient-friendly oral administration without an initial hormonal flare, providing a faster onset of action and improved treatment adherence.

The Phase 2 clinical trial of Merigolix in uterine fibroids was conducted by TiumBio’s partner, Daewon Pharmaceutical, and enrolled a total of 71 women diagnosed with uterine fibroids. Participants were randomly assigned to receive high, medium, or low doses of Merigolix, or placebo, administered orally once daily for 12 weeks, followed by a 12-week observation period. The results showed that Merigolix led to statistically significant improvements in heavy menstrual bleeding (HMB)—a validated clinical endpoint—across all dosage groups compared to the placebo.

In addition to the primary endpoint, Merigolix demonstrated statistically and clinically meaningful improvements in several key secondary endpoints, including fibroid size reduction, increased hemoglobin levels (indicating improved anemia), and relief of pelvic pain. The safety and tolerability profile of Merigolix was consistent with prior clinical data, with no new safety signs.

The mechanism of action of Merigolix can be used in various disorders, including endometriosis, uterine fibroids, ART, precocious puberty, and prostate cancer. Notably, in a separate Phase 2 clinical trial for endometriosis completed in 2024, Merigolix also showed excellent therapeutic efficacy and safety, further reinforcing its potential as a promising new treatment.

“We are very excited that Merigolix has demonstrated excellent therapeutic efficacy not only in endometriosis but also in uterine fibroids,” said Hun-Taek Kim, Ph.D., MBA, CEO of TiumBio. “successfully achieving both efficacy and safety in Phase 2 significantly increases the probability of regulatory approval and licensing opportunities. We plan to accelerate development and expand into the global uterine fibroid treatment market,” he added.

“Uterine fibroids are a condition that causes significant suffering for many women, and we believe Merigolix has the potential to become an important new oral treatment that addresses this unmet medical need,” said Jonathan In Baek, President of Daewon Pharmaceutical. “We are pleased with the positive results in uterine fibroids and will continue our efforts to provide patients with a convenient and effective new treatment option,” he continued.

Uterine fibroids are benign tumors that develop in the uterus, primarily affecting women of reproductive age, particularly those in their 30s and older. The condition has a high prevalence rate of approximately 20% among women over the age of 35. The most common symptom is heavy menstrual bleeding, but it can also cause abnormal uterine bleeding, pelvic pain, and anemia.

Meanwhile, TiumBio entered into a licensing agreement with Daewon Pharmaceutical in 2019, granting Daewon the rights to develop and commercialize Merigolix in South Korea.

About TiumBio Co., Ltd.

TiumBio (KRX: 321550.KQ) is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapeutics for patients with rare and incurable diseases. Its mission is to expand the hope and happiness of mankind through our science. TiumBio has three leading pipeline assets: Merigolix (code name: TU2670), TU2218, and TU7710, all in various stages of clinical development.

Merigolix is a once-daily, oral GnRH receptor antagonist being developed for the treatment of endometriosis, uterine fibroids, and assisted reproductive technology. TU2218 is a first-in-class oral immune-oncology therapy targeting TGF-β and VEGF pathways to promote response rates in cancer patients when used in combination with immune checkpoint inhibitors. TU7710 is a novel rFVIIa designed to extend its half-life in order to provide more clinical benefits to hemophilia patients with inhibitors.

With its expertise in drug development, TiumBio is committed to the discovery and development of innovative treatments to ease the burden of debilitating diseases. For further information, visit our website at www.tiumbio.com/en and connect with us on LinkedIn.

Contacts:

Junseok Jang, Head of Corporate Communications & Investor Relations
junseokjang@tiumbio.com

Da-ye Song, Manager, Corporate Communications & Investor Relations
dayesong@tiumbio.com

Zepp Health Corporation to Report First Quarter 2025 Financial Results on May 19, 2025

Earnings Call Scheduled for 9:00 p.m. ET on May 19, 2025

MILPITAS, Calif., May 7, 2025 /PRNewswire/ — Zepp Health Corporation (“Zepp Health” or the “Company”) (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it will report its first quarter 2025 unaudited financial results after the market close on Monday, May 19, 2025.

Management will hold a conference call at 9:00 p.m. Eastern Time on Monday, May 19, 2025. Listeners may access the call by dialing:

US (Toll Free):

+1-888-346-8982

International:

+1-412-902-4272

Mainland China (Toll Free):

400-120-1203

Hong Kong (Toll Free):

800-905-945

Hong Kong:

+852-3018-4992

Participants should dial in at least 10 minutes before the scheduled start time and ask to be connected to the call for “Zepp Health Corporation.”

Additionally, a live and archived webcast of the conference call will be available at http://ir.zepp.com.

A telephone replay will be available one hour after the end of the conference until May 26, 2025 by dialing the following telephone numbers:

US (Toll Free):            

+1-877-344-7529

International:

+1-412-317-0088

Replay Passcode:

5798726

 

About Zepp Health Corporation

Zepp Health Corporation (NYSE: ZEPP) is a global smart wearable and health technology leader, empowering users to live their healthiest lives by optimizing their health, fitness, and wellness journeys through its leading consumer brands, Amazfit, Zepp Clarity and Zepp Aura. Powered by its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors and data algorithms, Zepp delivers cloud-based 24/7 actionable insights and guidance to help users attain their wellness goals. To date, Zepp has shipped over 200 million units, and its products are available in more than 90 countries and regions. Founded in 2013 as Huami Corp., the Company changed its name to Zepp Health Corporation in February 2021 to emphasize its health focus with a name that resonates across languages and cultures globally. Zepp has team members and offices across globe, especially in Europe and USA regions.

For more information on Zepp Health and its products, please visit www.zepp.com.

For investor and media inquiries, please contact: 

Zepp Health Corporation
Grace Yujia Zhang
Email: ir@zepp.com 

Piacente Financial Communications
Email: zepp@tpg-ir.com